Search

everythinglearnresearchcommunity

for

Search:↓

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

Injectables can feminize or masculinize a transgender person's face, but more research is needed for best practices.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Spironolactone harms fish reproduction and is more potent in fish than invertebrates, needing environmental monitoring.

DHT is crucial for urethral formation, and its disruption can affect masculinization and lead to hypospadias.

Mouse genital development depends on male or female hormones for specific features.

After tumor removal, the woman regained normal hormone levels, menstruated, and had a healthy baby.

Androgen treatment with dihydrotestosterone may help maintain height in patients with 5-α-reductase type 2 deficiency, especially before puberty.

Gene mutations can cause problems in male genital development.

Finasteride exposure affects gene expression and anogenital distance in male rat fetuses.

Hyperandrogenism is a common hormonal disorder in women, often linked to PCOS.

New SRD5A2 variants may disrupt protein function, aiding diagnosis and treatment of related disorders.

Researchers should follow the FACE-Q User's Guide for accurate results.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

Women with congenital adrenal hyperplasia have lower fertility, but with proper treatment, they can conceive successfully.

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

PGD2 stops hair growth and is higher in bald men with AGA.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.